Physician profile
Anne E Campbell
NPI 1528559697
$10,550.09
in general payments reported to CMS, 2019-2025
59 companies · $1,898 in 2025
The $1,898 reported for 2025 was more than what 93% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,200 · 2022: $1,969 · 2023: $2,063 · 2024: $2,420 · 2025: $1,898.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,381.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,332.68 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,453.85 | 2021-2025 | Airsupra, Farxiga, Flumist Quadrivalent |
| Lilly USA, LLC | $811.41 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $787.69 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $448.48 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Amgen INC. | $354.47 | 2021-2023 | Prolia, Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $329.48 | 2021-2025 | Jardiance, Ofev |
| Bayer Healthcare Pharmaceuticals INC. | $300.46 | 2022-2025 | |
| Pfizer INC. | $229.71 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $229.29 | 2022-2025 | Rexulti, Nuedexta |
| Novartis Pharmaceuticals Corporation | $217.31 | 2021-2024 | |
| Medtronic, INC. | $194.52 | 2021-2025 | Intellis Adaptivestim |
| Idorsia Pharmaceuticals US INC | $187.23 | 2022-2023 | Quviviq |
| Takeda Pharmaceuticals U.S.A., INC. | $157.44 | 2021-2025 | Trintellix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $151.07 | 2022-2025 | Caplyta |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $144.04 | 2023-2025 | Edarbi, Edarbi |
| Janssen Pharmaceuticals, INC | $128.84 | 2021-2022 | |
| Exact Sciences Corporation | $127.61 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Axsome Therapeutics, INC. | $126.30 | 2022-2025 | Auvelity |
| Boston Scientific Corporation | $124.91 | 2022-2025 | Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $117.25 | 2021-2023 | Eliquis |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $116.81 | 2021-2024 | Xifaxan |
| Arbor Pharmaceuticals, INC. | $106.47 | 2021 | |
| Esperion Therapeutics, INC. | $93.42 | 2021-2025 | Nexletol |
| Ardelyx, INC. | $91.77 | 2024-2025 | Ibsrela |
| Biohaven Pharmaceuticals, INC. | $90.84 | 2021 | |
| Daiichi Sankyo INC. | $81.43 | 2021-2025 | Injectafer |
| Lundbeck LLC | $67.60 | 2024-2025 | Rexulti, Vyepti |
| Stryker Corporation | $67.17 | 2022 | |
| Amneal Pharmaceuticals LLC | $66.49 | 2022-2025 | Unithroid |
| Sanofi-Aventis U.S. LLC | $65.89 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $60.82 | 2021-2022 | |
| Astellas Pharma US INC | $60.21 | 2023-2025 | Veozah |
| Merck Sharp & Dohme LLC | $48.48 | 2021-2023 | Vaxneuvance, Pneumovax 23 |
| Biohaven Pharmaceutical Holding Company LTD. | $45.84 | 2022 | |
| Dexcom, INC. | $39.86 | 2025 | Dexcom G6 Transmitter |
| Axonics, INC. | $39.73 | 2022-2024 | Axonics |
| Inari Medical, INC. | $39.46 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amarin Pharma, INC. | $31.09 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $27.95 | 2025 | Voquezna |
| Rgh Enterprises LLC | $25.78 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $24.68 | 2021-2023 | Seglentis |
| Grifols USA, LLC | $23.94 | 2024 | Prolastin-C Liquid |
| Harmony Biosciences LLC | $23.45 | 2025 | |
| Edwards Lifesciences Corporation | $22.49 | 2025 | Sapien 3 Ultra Resilia |
| Ibsa Pharma INC. | $20.95 | 2022 | |
| Collegium Pharmaceutical, INC. | $20.62 | 2025 | Jornay Pm |
| Mannkind Corporation | $19.91 | 2022 | |
| Sumitomo Pharma America, INC. | $19.62 | 2025 | Gemtesa |
| Ironshore Pharmaceuticals INC. | $19.41 | 2024 | |
| Almatica Pharma LLC | $18.56 | 2021 | |
| Vanda Pharmaceuticals INC. | $16.70 | 2025 | Fanapt |
| Seqirus USA INC | $15.91 | 2021 | |
| Redhill Biopharma INC. | $15.71 | 2021 | |
| Philips North America LLC | $15.63 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $13.71 | 2024 | Uzedy |
| Avion Pharmaceuticals | $13.24 | 2022 | |
| Nevro Corp. | $12.40 | 2021 | |
| Genentech USA, INC. | $12.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.